153 related articles for article (PubMed ID: 33270814)
1. Characteristics of apoptosis induction in human breast cancer cells treated with a ceramidase inhibitor.
İzgördü H; Vejselova Sezer C; Çömlekçi E; Kutlu HM
Cytotechnology; 2020 Dec; 72(6):907-919. PubMed ID: 33270814
[TBL] [Abstract][Full Text] [Related]
2. (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase.
Bielawska A; Greenberg MS; Perry D; Jayadev S; Shayman JA; McKay C; Hannun YA
J Biol Chem; 1996 May; 271(21):12646-54. PubMed ID: 8647877
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ceramidase inhibition on human renal cell carcinoma: a cell culture study.
Palit F; Vejselova Sezer C; Kutlu HM
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(5 Suppl):121-129. PubMed ID: 37869957
[TBL] [Abstract][Full Text] [Related]
4. Neutral ceramidase gene: role in regulating ceramide-induced apoptosis.
Choi MS; Anderson MA; Zhang Z; Zimonjic DB; Popescu N; Mukherjee AB
Gene; 2003 Oct; 315():113-22. PubMed ID: 14557071
[TBL] [Abstract][Full Text] [Related]
5. Examining impacts of ceranib-2 on the proliferation, morphology and ultrastructure of human breast cancer cells.
Vejselova D; Kutlu HM; Kuş G
Cytotechnology; 2016 Dec; 68(6):2721-2728. PubMed ID: 27380965
[TBL] [Abstract][Full Text] [Related]
6. Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells.
Castillo SS; Teegarden D
J Nutr; 2001 Nov; 131(11):2826-30. PubMed ID: 11694603
[TBL] [Abstract][Full Text] [Related]
7. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
[TBL] [Abstract][Full Text] [Related]
8. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase.
Usta J; El Bawab S; Roddy P; Szulc ZM; Yusuf ; Hannun A; Bielawska A
Biochemistry; 2001 Aug; 40(32):9657-68. PubMed ID: 11583166
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in prostate cancer cells by the novel ceramidase inhibitor ceranib-2.
Kus G; Kabadere S; Uyar R; Kutlu HM
In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1056-63. PubMed ID: 26170224
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
[TBL] [Abstract][Full Text] [Related]
12. Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.
Tohyama J; Oya Y; Ezoe T; Vanier MT; Nakayasu H; Fujita N; Suzuki K
J Inherit Metab Dis; 1999 Jun; 22(5):649-62. PubMed ID: 10399097
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species.
Chan SY; Hilchie AL; Brown MG; Anderson R; Hoskin DW
Exp Mol Pathol; 2007 Feb; 82(1):1-11. PubMed ID: 16624283
[TBL] [Abstract][Full Text] [Related]
14. Proapoptotic effects of ceranib-2 in combination with radiation therapy on human breast cancer cells.
Tuğrul F; Vejselova Sezer C; Kutlu HM
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2322-2328. PubMed ID: 38567595
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer.
Selzner M; Bielawska A; Morse MA; Rüdiger HA; Sindram D; Hannun YA; Clavien PA
Cancer Res; 2001 Feb; 61(3):1233-40. PubMed ID: 11221856
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of Ceramidases.
Saied EM; Arenz C
Chem Phys Lipids; 2016 May; 197():60-8. PubMed ID: 26220616
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes.
Raisova M; Goltz G; Bektas M; Bielawska A; Riebeling C; Hossini AM; Eberle J; Hannun YA; Orfanos CE; Geilen CC
FEBS Lett; 2002 Apr; 516(1-3):47-52. PubMed ID: 11959101
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides.
Mao C; Xu R; Szulc ZM; Bielawski J; Becker KP; Bielawska A; Galadari SH; Hu W; Obeid LM
J Biol Chem; 2003 Aug; 278(33):31184-91. PubMed ID: 12783875
[TBL] [Abstract][Full Text] [Related]
20. Functions of neutral ceramidase in the Golgi apparatus.
Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
